[1] BATRA G, JAIN M, SINGH RS, et al. Novel therapeutic targets for amyotrophic lateral sclerosis[J]. Indian J Pharmacol, 2019, 51(6): 418. doi: 10.4103/ijp.IJP_823_19
[2] LIDDELOW SA, GUTTENPLAN KA, CLARKE LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia[J]. Nature, 2017, 541(7638): 481. doi: 10.1038/nature21029
[3] LIU J, WANG F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications[J]. Front Immunol, 2017, 8: 1005. doi: 10.3389/fimmu.2017.01005
[4] CHEN W, SHENG J, GUO J, et al. Cytokine cascades induced by mechanical trauma injury alter voltage-gated sodium channel activity in intact cortical neurons[J]. J Neuroinflammation, 2017, 14(1): 73. doi: 10.1186/s12974-017-0847-0
[5] JOLY-AMADO A, HUNTER J, QUADRI Z, et al. CCL2 overexpression in the brain promotes glial activation and accelerates tau pathology in a mouse model of tauopathy[J]. Front Immunol, 2020, 11: 997. doi: 10.3389/fimmu.2020.00997
[6] LONGINETTI E, FANG F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature[J]. Curr Opin Neurol, 2019, 32(5): 771. doi: 10.1097/WCO.0000000000000730
[7] KIERNAN MC, VUCIC S, CHEAH BC, et al. Amyotrophic lateral sclerosis[J]. Lancet, 2011, 377(9769): 942. doi: 10.1016/S0140-6736(10)61156-7
[8] BROWN RH, AL-CHALABI A. Amyotrophic lateral sclerosis[J]. N Engl J Med, 2017, 377(2): 162. doi: 10.1056/NEJMra1603471
[9] MATCOVITCH-NATAN O, WINTER DR, GILADI A, et al. Microglia development follows a stepwise program to regulate brain homeostasis[J]. Science, 2016, 353(6301): aad8670. doi: 10.1126/science.aad8670
[10] LIDDELOW SA, GUTTENPLAN KA, CLARKE LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia[J]. Nature, 2017, 541(7638): 481. doi: 10.1038/nature21029
[11] ZHAO W, BEERS DR, APPEL SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis[J]. J Neuroimmune Pharmacol, 2013, 8(4): 888. doi: 10.1007/s11481-013-9489-x
[12] BAN J, SÁMANO C, MLADINIC M, et al. Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets[J]. Croat Med J, 2019, 60(2): 109. doi: 10.3325/cmj.2019.60.109
[13] LALL D, BALOH RH. Microglia and C9 or f72 in neuroinflammation and ALS and frontotemporal dementia[J]. J Clin Invest, 2017, 127(9): 3250. doi: 10.1172/JCI90607
[14] RUSCONI M, GERARDI F, SANTUS W, et al. Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients′ peripheral blood[J]. Sci Rep, 2017, 7(1): 7853. doi: 10.1038/s41598-017-08233-1
[15] LIU S, HUANG Y, TAI H, et al. Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments[J]. J Neurol Neurosurg Psychiatry, 2018, 89(10): 1038. doi: 10.1136/jnnp-2018-318810
[16] HOBSON EV, MCDERMOTT CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis[J]. Nat Rev Neurol, 2016, 12(9): 526. doi: 10.1038/nrneurol.2016.111